Caso clínico
Trasplante renal exitoso con protocolo de eculizumab, timoglobulina y belatacept en paciente altamente sensibilizada con síndrome hemolítico urémico atípico por mutación del factor H
Successful kidney transplant with eculizumab, thymoglobulin and belatacept therapy in a highly-sensitised patient with atypical haemolytic uraemic syndrome due to factor H mutation
John Fredy Nieto-Ríosa,e,
, Mónica Zuluaga-Quinterob, Diana Carolina Bello-Márquezc, Arbey Aristizabal-Alzatea, Catalina Ocampo-Kohna,e, Lina María Serna-Higuitad, Lina Ariase, Gustavo Zuluaga-Valenciaa
Autor para correspondencia
a Departamento de Nefrología y Trasplante Renal,Hospital Pablo Tobón Uribe, Medellín, Colombia
b Departamento de Medicina Interna, Hospital Pablo Tobón Uribe, Medellín, Colombia
c Departamento de Nefrología, Centro Urogine, Medellín, Colombia
d Instituto de Bioestadística y Epidemiología Clínica, Hospital Universitario de Tübingen, Tübingen, Alemania
e Departamento de Medicina Interna y Nefrología, Universidad de Antioquia, Medellín, Colombia
Leído
15784
Vecesse ha leído el artículo
4099
Total PDF
11685
Total HTML
Compartir estadísticas
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2026 1 | 158 | 149 | 307 |
| 2025 12 | 264 | 218 | 482 |
| 2025 11 | 229 | 116 | 345 |
| 2025 10 | 178 | 47 | 225 |
| 2025 9 | 169 | 44 | 213 |
| 2025 8 | 138 | 55 | 193 |
| 2025 7 | 133 | 26 | 159 |
| 2025 6 | 162 | 37 | 199 |
| 2025 5 | 195 | 49 | 244 |
| 2025 4 | 186 | 21 | 207 |
| 2025 3 | 204 | 54 | 258 |
| 2025 2 | 187 | 24 | 211 |
| 2025 1 | 183 | 31 | 214 |
| 2024 12 | 117 | 30 | 147 |
| 2024 11 | 123 | 52 | 175 |
| 2024 10 | 116 | 43 | 159 |
| 2024 9 | 108 | 26 | 134 |
| 2024 8 | 427 | 86 | 513 |
| 2024 7 | 132 | 34 | 166 |
| 2024 6 | 113 | 43 | 156 |
| 2024 5 | 142 | 37 | 179 |
| 2024 4 | 147 | 50 | 197 |
| 2024 3 | 102 | 27 | 129 |
| 2024 2 | 100 | 45 | 145 |
| 2024 1 | 85 | 31 | 116 |
| 2023 12 | 72 | 33 | 105 |
| 2023 11 | 79 | 44 | 123 |
| 2023 10 | 147 | 35 | 182 |
| 2023 9 | 302 | 31 | 333 |
| 2023 8 | 276 | 29 | 305 |
| 2023 7 | 137 | 23 | 160 |
| 2023 6 | 232 | 30 | 262 |
| 2023 5 | 144 | 61 | 205 |
| 2023 4 | 89 | 32 | 121 |
| 2023 3 | 102 | 27 | 129 |
| 2023 2 | 69 | 43 | 112 |
| 2022 1 | 100 | 48 | 148 |
| 2022 12 | 109 | 52 | 161 |
| 2022 11 | 85 | 47 | 132 |
| 2022 10 | 114 | 56 | 170 |
| 2022 9 | 111 | 52 | 163 |
| 2022 8 | 77 | 64 | 141 |
| 2022 7 | 85 | 77 | 162 |
| 2022 6 | 82 | 48 | 130 |
| 2022 5 | 101 | 44 | 145 |
| 2022 4 | 132 | 61 | 193 |
| 2022 3 | 103 | 48 | 151 |
| 2022 2 | 81 | 51 | 132 |
| 2021 1 | 69 | 48 | 117 |
| 2021 12 | 83 | 49 | 132 |
| 2021 11 | 109 | 49 | 158 |
| 2021 10 | 135 | 60 | 195 |
| 2021 9 | 83 | 40 | 123 |
| 2021 8 | 76 | 50 | 126 |
| 2021 7 | 48 | 38 | 86 |
| 2021 6 | 79 | 36 | 115 |
| 2021 5 | 80 | 63 | 143 |
| 2021 4 | 136 | 101 | 237 |
| 2021 3 | 93 | 51 | 144 |
| 2021 2 | 90 | 56 | 146 |
| 2020 1 | 83 | 30 | 113 |
| 2020 12 | 70 | 24 | 94 |
| 2020 11 | 71 | 20 | 91 |
| 2020 10 | 72 | 37 | 109 |
| 2020 9 | 80 | 40 | 120 |
| 2020 8 | 79 | 33 | 112 |
| 2020 7 | 69 | 18 | 87 |
| 2020 6 | 83 | 24 | 107 |
| 2020 5 | 101 | 26 | 127 |
| 2020 4 | 70 | 25 | 95 |
| 2020 3 | 79 | 16 | 95 |
| 2020 2 | 115 | 37 | 152 |
| 2020 1 | 100 | 41 | 141 |
| 2019 12 | 99 | 34 | 133 |
| 2019 11 | 119 | 34 | 153 |
| 2019 10 | 133 | 43 | 176 |
| 2019 9 | 142 | 34 | 176 |
| 2019 8 | 148 | 48 | 196 |
| 2019 7 | 114 | 42 | 156 |
| 2019 6 | 104 | 31 | 135 |
| 2019 5 | 136 | 55 | 191 |
| 2019 4 | 159 | 77 | 236 |
| 2019 3 | 105 | 37 | 142 |
| 2019 2 | 73 | 37 | 110 |
| 2019 1 | 81 | 36 | 117 |
| 2018 12 | 126 | 58 | 184 |
| 2018 11 | 167 | 17 | 184 |
| 2018 10 | 144 | 12 | 156 |
| 2018 9 | 324 | 17 | 341 |
| 2018 8 | 166 | 28 | 194 |
| 2018 7 | 130 | 14 | 144 |
| 2018 6 | 93 | 15 | 108 |
| 2018 5 | 42 | 7 | 49 |
Mostrar todo
